FDA Inspection 1216528 — Romark Laboratories, L.C.
The FDA completed an inspection of Romark Laboratories, L.C. on August 23, 2023 in Tampa, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 23, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tampa, FL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)